Review of long term immunogenicity and tolerability of live hepatitis A vaccine
Hepatitis A represents one of the major public health problems worldwide including India. Vaccination is the most effective way to prevent hepatitis A infection. Two types of hepatitis A vaccines-live attenuated (H2 strain) and inactivated (killed) are available for use in clinical practice in India...
Main Authors: | Nitin Shah, MMA Faridi, Monjori Mitra, Ashish Bavdekar, Archana Karadkhele, Gaurav Puppalwar, Rishi Jain |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2020.1741997 |
Similar Items
-
Five-year antibody persistence in children after one dose of inactivated or live attenuated hepatitis A vaccine
by: Zhilun Zhang, et al.
Published: (2017-06-01) -
Impact of Obesity and Being Overweight on the Immunogenicity to Live Attenuated Hepatitis A Vaccine in Children and Young Adults
by: Termpong Dumrisilp, et al.
Published: (2021-02-01) -
Safety and immunogenicity of VAQTA® in children 12-to-23 months of age with and without administration of other US pediatric vaccines
by: Maria Petrecz, et al.
Published: (2019-02-01) -
Influences of obesity on the immunogenicity of Hepatitis B vaccine
by: Fang Liu, et al.
Published: (2017-05-01) -
Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
by: Dapeng Sun, et al.
Published: (2023-01-01)